SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1420F21CDCC08B9E4B55D4403BBAE7A98803421A86DA2765FB9C8EC517393843CC633510F18884454655A26FBCC9CF49>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1420F21CDCC08B9E4B55D4403BBAE7A98803421A86DA2765FB9C8EC517393843CC633510F18884454655A26FBCC9CF49
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1420F21CDCC08B9E4B55D4403BBAE7A98803421A86DA2765FB9C8EC517393843CC633510F18884454655A26FBCC9CF49
http://www.w3.org/2000/01/rdf-schema#comment
"The bevacizumab-independent VEGF/NRP1/ARHGAP17/Cdc42 regulatory network plays important roles in malignant behavior of breast cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_17F224897B1606B137EDBE175C50670E1DE8949472C2DF0BBB738055CDDC5D25965A1D4FEA4E0429FA19EE8C1D62A046
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1420F21CDCC08B9E4B55D4403BBAE7A98803421A86DA2765FB9C8EC517393843CC633510F18884454655A26FBCC9CF49
http://purl.uniprot.org/uniprot/Q8WY69
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1420F21CDCC08B9E4B55D4403BBAE7A98803421A86DA2765FB9C8EC517393843CC633510F18884454655A26FBCC9CF49
http://purl.uniprot.org/uniprot/#_Q8WY69-mappedCitation-29971782
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1420F21CDCC08B9E4B55D4403BBAE7A98803421A86DA2765FB9C8EC517393843CC633510F18884454655A26FBCC9CF49